)
Investor Relations14 Oct 2025
Boost Your Earnings Season Strategy With Real‑Time Alerts
Quartr Pro provides real time alerts, trend analysis and live coverage, giving analysts and investors instant insights to act faster in earnings.
Modus Therapeutics (MODTX) investor relations material
Modus Therapeutics Q2 2025 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Q2 2025 earnings summary7 Aug, 2025
Executive summary
Completed Part 1 of Phase IIa trial for sevuparin in CKD anemia; dose selection finalized for Part 2, which is on track to start in Q4 2025.
Presented new preclinical data showing sevuparin improves hemoglobin and kidney status in CKD models.
Secured shareholder approval for a fully guaranteed rights issue of SEK 28.3 million to fund continued clinical development.
Expanded clinical trial sites and completed patient enrollment on schedule, supporting future milestones.
Broadened commercial and partnership discussions, with ongoing business development in malaria and sepsis programs.
Financial highlights
Q2 2025 loss after tax: TSEK 6,066 (vs. 4,738 in Q2 2024); H1 2025 loss after tax: TSEK 8,881 (vs. 7,843 in H1 2024).
Q2 2025 loss per share: SEK 0.17 (vs. 0.13); H1 2025 loss per share: SEK 0.25 (vs. 0.22).
Cash flow from operating activities Q2 2025: negative TSEK 3,423 (vs. 3,425); H1 2025: negative TSEK 7,482 (vs. 7,090).
Cash and cash equivalents at June 30, 2025: TSEK 1,897 (vs. 11,971 at June 30, 2024).
Shareholder's equity at June 30, 2025: TSEK -6,744 (vs. 9,839 at June 30, 2024).
Outlook and guidance
Part 2 of the Phase IIa CKD anemia study to begin in Q4 2025, with funding secured for continued development.
Rights issue proceeds and potential warrant exercises expected to finance operations through end of 2026.
Focus remains on clinical progress in CKD anemia, with additional business development in malaria and sepsis.
How long will current funding last?
What commercial incentives exist for malaria?
What regulatory flexibilities may sevuparin qualify?
Partial view of Summaries dataset, powered by Quartr API
Research faster. Power your platform.
Next Modus Therapeutics earnings date
Q3 202526 Nov, 2025
Next Modus Therapeutics earnings date
Q3 202526 Nov, 2025
The essential earnings season companion
The #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
)
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
Related articles
)
Edge3 Oct 2025
Epiroc: A Culture of Moving Mountains
From automation to electrification, Swedish industrial giant Epiroc is leading a transformation in how the world mines.
)
Company Research22 Sep 2025
Moody's: Shaping Global Credit
Explore Moody's evolution from publishing manuals to becoming a giant in credit ratings, guiding issuers, investors, and regulators worldwide.
Frequently asked questions
Modus Therapeutics Holding is a clinical-stage biopharmaceutical company developing therapies for diseases related to inflammation and blood flow disorders. Its lead programs focus on treatments for conditions such as sepsis and sickle cell disease. The company is headquartered in Stockholm, Sweden, and its shares are listed on the Nasdaq First North Growth Market.
Quartr provides global coverage of all investor relation material from public companies.
Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.
Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.
Yes, the Quartr mobile app is free on both iOS and Android.
Yes. Quartr provides global, industry-leading live coverage of company events such as regular earnings calls, capital markets days, M&A announcements, and investor conferences. Live with zero delays. Just click and listen.
Yes, capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Yes. Follow the companies that matter to you. Get a personalized feed with real-time updates, a tailored earnings calendar, and instant alerts when earnings calls go live.
Yes. Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned, regardless of who's talking.
Explore our global coverage